Impaktované publikace
Tiede, A.; Collins, P.; Knoebl, P.; Teitel, J.; Kessler, C.; Shima, M.; Di Minno, G.; D´ Oiron, R.; Salaj, P.; et al.
International recommendations on the diagnosis and treatment of acquired hemophilia
[rok vydání 2020, impact factor 9.941 ]
Kotlín, R.; Reicheltová, Z.; Malý, M.; Suttnar, J.; Sobotková, A.; Salaj, P.; Hirmerová, J.; Riedel, T.; Dyr, J.E.
Two cases of congenital dysfibrinogenemia associated with thrombosis : Fibrinogen Praha III and Fibrinogen Plzen
[rok vydání 2009, impact factor 4.451]
Salaj, P.; Geierová, V.; Ivanová, E.; Loužil, J.; Pohlreichová, V.; Hrachovinová, I.; Dulíček, P.
Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: results from a Czech patient cohort
[rok vydání 2020, impact factor 4.287 ]
Kotlín, R.; Reicheltová, Z.; Sobotková, A.; Suttnar, J.; Salaj, P.; Pospíšilová, D.; Smejkal, P.; Chrastinová, L.; Dyr, J.E.
Three cases of abnormal fibrinogens : Šumperk (Bbeta His67Leu), Uničov (Bbeta Gly414Ser), and Brno (gammaArg275His)
[rok vydání 2008, impact factor 3.803]
Salaj, P.; Ovesna, P.; Penka, M.; Hedner, U.
Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors
[rok vydání 2012, impact factor 3.170 ]
Salaj, P.; Penka, M.; Smejkal, P.; Geierova, V.; Ovesna, P.; Brabec, P.; Cetkovsky, P.; Kubes, R.; Mesterton, J.; Lindgren, P.
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic
[rok vydání 2012, impact factor 3.133 ]
Fuchs, O.; Provaznikova, D.; Kocova, M.; Kostecka, A.; Cvekova, P.; Neuwirtova, R.; Kobylka, P.; Cermak, J.; Brezinova, J.; Schwarz, J.; Markova, J.; Salaj, P.; Klamova, H.; Maaloufova, J.; Lemez, P.; Novakova, L.; Benesova, K.
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin´s lymphoma
[rok vydání 2008, impact factor 2.749]
Provaznikova, D.; Houskova, K.; Radovska, A.; Salaj, P.; Hrachovinova, I.
Novel mutations associated with a discrepancy between one-stage and chromogenic FVIII activity assays
[rok vydání 2015, impact factor 2.673 ]
Křížová, P.; Mášová, L.; Suttnar, J.; Salaj, P.; Dyr, J.E.; Homola, J.; Pecka, M.
The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose
[rok vydání 2007, impact factor 2.612]
Shapiro, A.D.; Neufeld, E.J.; Blanchette, V.; Salaj, P.; Gut, R.Z.; Cooper, D.L.
Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg-1) rFVIIa doses across clinical trials and registries
[rok vydání 2014, impact factor 2.603 ]
Salaj, P.; Brabec, P.; Penka, M.; Pohlreichova, V.; Smejkal, P.; Cetkovsky, P.; Dusek, L.; Hedner, U.
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors : analysis of HemoRec registry data from the Czech Republic
[rok vydání 2009, impact factor 2.505]
Santagostino, E.; Morfini, M.; Auerswald, G.K.; Benson, G.M.; Šalek, S.Z.; Lambert, T.; Salaj, P.; Jimenez-Yuste, V.; Ljung, R.C.R.
Paediatric haemophilia with inhibitors : existing management options, treatment gaps and unmet needs
[rok vydání 2009, impact factor 2.505]
Pan-Petesch, B.; Laguna, P.; Mital, A.; Stanley, J.; Torchet, M.F.; Salek, S.Z.; Salaj, P.
Single-dose (270 µg kg-1) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors : experience from seven European haemophilia centres
[rok vydání 2009, impact factor 2.505]
Salaj, P.; Gurlich, R.; Svorcova, V.; Markova, M.; Cetkovsky, P.
Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa
[rok vydání 2008, impact factor 2.505]
Salaj, P.; Kubes, R.; Cetkovsky, P.; Capova, I.; Penka, M.; Ovesna, P.; Mesterton, J.; Lindgren, P.
Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry
[rok vydání 2013, impact factor 2.447 ]
Kotlín, R.; Pastva, O.; Štikarová, J.; Hlaváčková, A.; Suttnar, J.; Chrastinová, L.; Riedel, T.; Salaj, P.; Dyr, J.E.
Two novel mutations in the fibrinogen gamma nodule
[rok vydání 2014, impact factor 2.447 ]
Kotlín, R.; Zichová, K.; Suttnar, J.; Reicheltová, Z.; Salaj, P.; Hrachovinová, I.; Dyr, J.E.
Congenital dysfibrinogenemia Aalpha Gly13Glu associated with bleeding during pregnancy.
[rok vydání 2010, impact factor 2.440]
Maly, M.; Hrachovinova, I.; Tomasov, P.; Salaj, P.; Hajek, P.; Veselka, J.
Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma : a pilot study
[rok vydání 2008, impact factor 2.345]
Provaznikova, D.; Kumstyrova, T.; Kotlin, R.; Salaj, P.; Matoska, V.; Hrachovinova, I.; Rittich, S.
High-resolution melting analysis for detection of MYH9 mutations
[rok vydání 2008, impact factor 2.271]
Kotlín, R.; Sobotková, A.; Suttnar, J.; Salaj, P.; Walterová, L.; Riedel, T.; Reicheltová, Z.; Dyr, J.E.
A novel fibrinogen variant - Liberec : dysfibrinogenaemia associated with gamma Tyr262Cys substitution
[rok vydání 2008, impact factor 2.237]